 China Biologic Products NASDAQ:CBPO was upgraded by BidaskClub from a strong sell rating to a sell rating in a report released on Tuesday, BidAskClub reports. Separately, ValuEngine lowered China Biologic Products from a hold rating to a sell rating in a research report on Tuesday, February 4th. Three research analysts have rated the stock with ... 